Literature DB >> 20038390

[Detecting adverse drug events during the hospital stay].

C Berga Culleré1, M Q Gorgas Torner, J Altimiras Ruiz, M Tuset Creus, M Besalduch Martín, M Capdevila Sunyer, M Torres Gubert, M T Casajoana Cortinas, E Baró Sabaté, J R Fernández Solà, A Moron i Besolí, E Odena Estradé, J Serrais Benavente, M T Vitales Farrero, C Codina Jané.   

Abstract

INTRODUCTION: The principal objective was to determine the incidence rate of adverse drug events (ADEs) in hospitalised patients and evaluate the event prevention percentage.
METHODS: Multi-centre, prospective observational study lasting four months, performed in five hospitals providing different levels of care. We included all adult patients who were admitted to one of the selected centres for longer than 48 hours and who required pharmacological treatment. ADEs were identified by direct observation and the use of previously defined alarm signals. The Karch-Lasagna scale was used to determine the causality relationship, and the Schumock and Thornton questionnaire adapted by Otero was used to evaluate ADE preventability. Preventable drug-induced adverse events were classified according to the taxonomy that the Ruiz-Jarabo 2000 group defined, and coordinated by ISMP-Spain.
RESULTS: We included 1,550 patients, 159 of whom experienced at least one ADE (10.3 %). The preventability percentage was 51.6 %, which represented 5.3 % of the total sample. The endocrine system (34.8 %) and the cardiovascular system (20.7 %) were the most affected by preventable ADEs. Antibiotics were responsible for 16.5 % of all ADEs. 9.3 % of all preventable ADEs were triggered by use of opiates. The vast majority of preventable ADEs (36.3 %) resulted from omitting a necessary medication. Only 4.4 % of preventable ADEs are considered to be serious.
CONCLUSIONS: There is a high incidence rate of ADEs during patients' hospital stay (10.3 %), and half of them (51.6 %) could have been prevented. Implementation of an automatic alarm system and certain best practices for problem spots along the care circuit will help detect and avoid preventable ADEs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20038390

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  4 in total

1.  Adverse drug events in surgical patients: an observational multicentre study.

Authors:  Monica de Boer; Eveline B Boeker; Maya A Ramrattan; Jordy J S Kiewiet; Marcel G W Dijkgraaf; Marja A Boermeester; Loraine Lie-A-Huen
Journal:  Int J Clin Pharm       Date:  2013-05-31

2.  An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients.

Authors:  Eveline B Boeker; Kim Ram; Joanna E Klopotowska; Monica de Boer; Montse Tuset Creus; Ana L de Andrés; Mio Sakuma; Takeshi Morimoto; Marja A Boermeester; Marcel G W Dijkgraaf
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

3.  Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial.

Authors:  Ana Juanes; Noe Garin; Maria Antonia Mangues; Sergio Herrera; Mireia Puig; Maria Jose Faus; Maria Isabel Baena
Journal:  Eur J Hosp Pharm       Date:  2017-02-23

Review 4.  Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature.

Authors:  Eveline B Boeker; Monica de Boer; Jordy J S Kiewiet; Loraine Lie-A-Huen; Marcel G W Dijkgraaf; Marja A Boermeester
Journal:  BMC Health Serv Res       Date:  2013-09-28       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.